imAGEin Programme gathers the expertise of five european universities in France, Spain, Portugal and Germany:
The Université Côte d'Azur has the status of a Grand Établissement. It is a recipient of the prestigious national "IdEx" label for initiatives of excellence, positioning it among the nine French "IdEx" universities that are research-intensive and have strong international influence. Organized into innovative internal components with increased responsibilities for greater agility, the University Côte d'Azur anchors all its educational and innovation missions in the excellence of its research.
As a founding member of the European alliance Ulysseus, the host of one of France's four Interdisciplinary Institutes for Artificial Intelligence (3IA), and with major partnerships with leading national research organizations, the University Côte d'Azur aims to rank among the best European universities and further solidify its international presence.
The University includes CNRS/INSERM research institutes as the Institute for Research and Cancer and Ageing (IRCAN), the Institute of Molecular and Cellular Pharmacology (IPMC), the Institute of Biology Valrose (iBV), the Mediterranean Center for Molecular Medicine (C3M) and the Laboratoire de PhysioMédecine Moléculaire (LP2M).
University of Cologne is one of the largest Universities in Germany, UoC has developed the theme of aging-associated diseases as one of its key profile areas. The cluster of Excellence: Cellular Stress Responses in Aging-associated Diseases (CECAD) is a worldwide leading epicenter of aging research. CECAD has built a unique focus on organismal studies on aging that use cutting edge technology to investigate the mechanisms of aging in the physiological context. Based on the strong synergies between the biologists and clinician scientists within CECAD, the students will receive comprehensive education on the mechanisms of age-related diseases and how organismal studies can identify causes and mechanisms of human diseases and develop the therapies of the future.
Sciences Sorbonne Université is a world-class research university, presenting a comprehensive range of disciplines from arts, humanities, social sciences to biological sciences, engineering and medicine. Training in the Aging and Longevity track is based on the recognized expertise of academics from SU, CNRS/INSERM researchers, private organizations (pharmaceutical and cosmetics industry, biotech) and hospitals. There is a privileged partnership with the teams of the Paris-Seine Institute of Biology, particularly within its Biological Adaptation and Aging department located on the main Pierre and Marie Curie Campus and in which studies are focused on stress responses, adaptation, resilience and repair, as well as with other teams from the Cordeliers Research Center, the Vision Institute, the Brain and Spinal Cord Institute, the Myology Institute and UPMC SU university hospitals (Pitié-Salpêtrière, Charles-Foix and Saint-Antoine).
University of Seville is a founder and the coordinator of Ulysseus European University. All the assigned teaching staff from USE carry out an outstanding research and technology transfer activity in molecular mechanisms linked to ageing and neurodegeneration at two research centers, namely CABIMER (Center for Molecular Biology and Regenerative Medicine) and IBIS (Institute of Biomedicine of Seville). CABIMER is dedicated to DNA damage, one of the leading causes of ageing, and regenerative medicine, one of the most promising field for anti-ageing interventions. The USE assigned teaching staff working at CABIMER/IBIS in different aspects related to ageing have close ties to the Hospital Universitario Virgen del Rocío (HUVR) University of Seville Hospital.
University of Coimbra has a strong focus on aging research, with two institutes, the Center for Innovative Biomedicine and Biotechnology (CIBB) and the Multidisciplinary Institute of Ageing (MIA), conducting intense research programmes in this area. CIBB is home to the largest group of biomedical and biotechnology investigators in the region of Portugal and hosts 600 members, including 298 integrated PhD holders and clinicians from the Coimbra University Hospital and healthcare system, as well as key collaborators from the biotech and pharmaceutical industries. MIA, a partnership between UC, the University of Newcastle, the University Medical Center Groningen, Copenhagen University and Mayo Clinic, focuses on bridging the gap between top-level research in aging and its application in clinical and geriatric care.
ImAGEin students who select the University of Coimbra will have the opportunity of externalization to the partners from the Multidisciplinary Institute of Ageing, namely the University Medical Center Groningen (UMCG) hosting the European Institute for the Biology of Ageing (ERIBA). CIBB researchers at UC also coordinate a regional consortium - Ageing@Coimbra - which has been recognized by the European Commission as a Reference Site of the European Innovation Partnership on Active and Healthy Aging (EIP on AHA). This consortium aims to transfer innovative knowledge on aging research and provide support for healthy living and innovative solutions to the market. UC has a strong track record of success in competitive EIT Health, H2020, and Horizon projects focusing on ageing, including the Teaming for the Multidisciplinary Institute of Ageing (MIA-Portugal), the ERA Chair on Aging, the Collaborative Laboratory of Aging (CoLab4Ageing), the Excellence Hub project on Aging (Changing), and is the coordinator of the international EIT Health Aging PhD School.